Monday to Sunday, including holidays: 8h - 20h
Phone number: 282 420 020
Av. S. João de Deus - Parque de Saúde da Misericordia de Portimão,
8500-508 Portimão
Opening Hours
Monday to Friday: 7am - 10pm
Saturdays, Sundays and Bank Holidays: 8 am - 10 pm
Urgent Care
Daily: 8am - 9pm
Clinical Analysis
Monday to Friday: 7am - 8pm
SaturdaySunday and Bank Holidays: 8am - 8pm
Av. General Humberto Delgado, Lote 7 7520-103 Sines
request appointment / exam
search
contacts
waiting times
Hospital Particular Alvor
00h00mAtendimento Urgente
Hospital Particular Gambelas
00h00mAtendimento Urgente
Superior a 1H30Pediatria
Hospital Particular da Madeira
Superior a 1H30Atendimento Urgente
00h00mPediatria
Madeira Medical Center
00h00mAtendimento Urgente
waiting times
Hospital Particular Alvor
00h00mAtendimento Urgente
Hospital Particular Gambelas
00h00mAtendimento Urgente
Superior a 1H30Pediatria
Hospital Particular da Madeira
Superior a 1H30Atendimento Urgente
00h00mPediatria
Madeira Medical Center
00h00mAtendimento Urgente
Pode ainda contactar-nos através do 282 42 04 00 Algarve | 269 630 370 Alentejo | 291 003 300 Madeira
(Chamada para a rede fixa nacional)Request Appointment/Request Exam - After completing the respective forms, these requests will be processed by our services, and you will receive confirmation by email. The indications about the Agreements (Insurance/Subsystem) are merely informative, please request confirmation in the "Observations" field.
Schedule Appointment/Exam myHPA - By accessing myHPA Saúde you can make the appointment in real time, directly on the Doctor's schedule according to his availability.
You can also contact us at +351 282 420 400 Algarve | +351 269 630 370 Alentejo | +351 291 003 300 Madeira
(National landline)
Your request has been successfully received. We will confirm your appointment shortly.
Download myHPA Saúde:
HPA Health Group Newsletter:
Subscribe and stay up to date with all the news!
Oncologista
HPA Magazine 13
Given the exponential growth and the medical care provided by the Oncology Day Care Hospital, it is essential to complement the treatment and care provided to patients with scientific research. As a rapidly evolving medical specialty, sharing knowledge and peer experience is essential to attest to the true value of cancer treatments in clinical practice. The Oncology Unit is committed to keeping scientific activity one of its priorities, as well as providing pioneering clinical trials in the region.
Given the exponential growth and the medical care provided by the Oncology Day Care Hospital, it is essential to complement the treatment and care provided to patients with scientific research. As a rapidly evolving medical specialty, sharing knowledge and peer experience is essential to attest to the true value of cancer treatments in clinical practice. The Oncology Unit is committed to keeping scientific activity one of its priorities, as well as providing pioneering clinical trials in the region.
A clinical trial presupposes collaboration between physicians, patients and promoters to investigate new clinical procedures or new drugs to identify, prevent or treat disease. Clinical trials involving drugs can be carried out at doctors' consulting rooms, clinics or study centers. There are types of clinical trials according to the hypothesis to be validated and a statistical methodology used. They involve rigorous and impartial preparation, planning and interpretation of the data obtained. The resulting information is of great importance to the evolution of medical practice, as it permits the evaluation of the added value of a given experimental treatment, comparing it to the current “standard-of-care” in a given population. For a trial to be statistically significant, it is essential that it involves a large number of patients, so that its outcome may eventually be integrated into clinical practice.
At the HPA Oncology Unit, the KEYNOTE-630 clinical trial is currently under recruitment, aiming to assess the benefit of adjuvant immunotherapy compared to surveillance in patients with high-risk cutaneous squamous cell carcinoma undergoing radiotherapy. Short-term prospects include the inclusion of our center in other clinical trials, including digestive disorders.
International recommendations advocate integration into a clinical trial as the best treatment option for the vast majority of cancer patients, which well reflects its importance in clinical practice. There is a natural tendency internationally for these trials to be centralized in large hospitals and academic cancer centers, however, and because they cannot treat all patients in a timely manner, there is an indispensable and growing link with more peripheral hospitals. Thus, promoters extend trials to more peripheral centers by recognizing the volume and quality of patient care. It is this phenomenon that we have been experiencing in our Unit and for which we work on a daily basis.
We believe that in the demographic context of the Algarve, given the obvious geographical distance from the capital, it is extremely important to be able to make this additional treatment option available to the cancer patient. Thus, the promotion of health literacy and the demystification of the concept associated with clinical trials, is also extremely important; This is not a random laboratory experiment, but a guarantee of quality and accuracy of the best possible treatment.